Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Int J Infect Dis ; 122: 550-552, 2022 Sep.
Article in English | MEDLINE | ID: covidwho-1966624

ABSTRACT

Burkholderia cepacia complex (BCC) is nonfermenting, Gram-negative bacteria known to cause high morbidity and mortality. They commonly affect patients with cystic fibrosis (CF) and are often missed in those without, despite being fatal if left untreated. We report a case of cepacia syndrome in a 42-year-old, immunocompetent man without CF who initially presented with sepsis secondary to pneumonia. Multiple isolates from blood, synovial fluid, and wound swabs grew BCC. Treatment options and management strategies remain poorly understood for BCC in general and in cases without CF in specific. We successfully treated the patient using a combination of intravenous and inhalational antibiotics. This case report elaborates on the disease presentation, investigations, and management strategy employed to treat this rare infection.


Subject(s)
Burkholderia Infections , Burkholderia cepacia complex , Cystic Fibrosis , Adult , Anti-Bacterial Agents/therapeutic use , Burkholderia Infections/diagnosis , Burkholderia Infections/drug therapy , Cystic Fibrosis/complications , Cystic Fibrosis/microbiology , Fibrosis , Humans , Male , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL